Episodes

Thursday Aug 15, 2019
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Thursday Aug 15, 2019
Thursday Aug 15, 2019
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
Version: 20241125
No comments yet. Be the first to say something!